Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model
Author(s) -
J. P. Dalton,
Brian Uy,
Kazuhide S. Okuda,
Christopher J. Hall,
William A. Denny,
Philip S. Crosier,
Simon Swift,
Siouxsie Wiles
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw421
Subject(s) - mycobacterium marinum , rifampicin , biology , zebrafish , tuberculosis , mycobacterium tuberculosis , microbiology and biotechnology , mycobacterium , population , pathogen , virology , antibiotics , medicine , pathology , biochemistry , gene , environmental health
Mycobacterium tuberculosis is a deadly human pathogen that causes the lung disease TB. M. tuberculosis latently infects a third of the world's population, resulting in ∼1.5 million deaths per year. Due to the difficulties and expense of carrying out animal drug trials using M. tuberculosis and rodents, infections of the zebrafish Danio rerio with Mycobacterium marinum have become a useful surrogate. However, the infection methods described to date require specialized equipment and a high level of operator expertise.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom